Two-photon fluorescence imaging has attracted increasing interest in the biological and medical fields because of its low cell damage, high resolution, large imaging depth, and easy dynamic observation. A high-performance two-photon probe with long-term imaging capability was proposed for this imaging technology. In this work, a new two-photon probe compound was synthesized from tetraphenylethylene fluorogen with aggregation-induced emission. A phenyl-[phenyl-(1,2,5-thialdiazol)] amine group was induced to red-shift the absorption and emission wavelengths of the compound. After self-assembly, fluorescent dots with aggregation-induced emission cores and hydrophobic shells terminated by -COOH were formed. Cell experiments proved that the 4-(7-(phenyl(4-(1,2,2-triphenylvinyl)phenyl)amino)benzo[c][1,2,5]thiadiazol-4-yl)benzoic acid (TPECOOH) dots with red emission showed good biocompatibility and excellent two-photon imaging ability. TPECOOH dots were used successfully in direct long-term cell imaging with high efficiency. Even after twelve days, fluorescence imaging could still be observed in live HeLa cells.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: